About Centre Hospitalier de Mulhouse
Le groupe hospitalier de la région de Mulhouse et Sud-Alsace est un groupe hospitalier regroupant 10 établissements dans le Haut-Rhin, en région Grand Est.
Clinical Trials at Centre Hospitalier de Mulhouse
During the past decade, Centre Hospitalier de Mulhouse conducted 77 clinical trials. In the 10-year time frame, 77 clinical trials started and 11 clinical trials were completed, i.e. on
average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 8 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centre Hospitalier de Mulhouse" #1 sponsor was "Intergroupe Francophone de Cancerologie Thoracique" with 26 trials, followed by "Groupe Hospitalier de la Region de Mulhouse et Sud Alsace" with 10 trials
sponsored, "UNICANCER" with 8 trials sponsored, "The Lymphoma Academic Research Organisation" with 7 trials sponsored and "University Hospital, Strasbourg, France"
with 7 trials sponsored. Other sponsors include 72 different institutions and
companies that sponsored additional 58 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier de Mulhouse"
#1 collaborator was "Poitiers University Hospital" with 5 trials as a collaborator, "Centre Hospitalier Universitaire Dijon" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "Central Hospital, Nancy, France" with 3 trials as a collaborator and "Centre Hospitalier Universitaire de Nīmes" with 3 trials as a collaborator. Other collaborators include 161 different institutions and companies that were
collaborators in the rest 148 trials.
Clinical Trials Conditions at Centre Hospitalier de Mulhouse
According to Clinical.Site data, the most researched conditions in "Centre Hospitalier de Mulhouse" are
"Breast Cancer" (8 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials), "Acute Myeloid Leukemia" (3 trials), "Colorectal Cancer" (3 trials) and "Lung Cancer" (3 trials). Many other conditions were trialed in "Centre Hospitalier de Mulhouse" in a lesser frequency.
Clinical Trials Intervention Types at Centre Hospitalier de Mulhouse
Most popular intervention types in "Centre Hospitalier de Mulhouse" are "Drug" (85 trials), "Procedure" (22 trials), "Other" (16 trials), "Radiation" (11 trials) and "Behavioral" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "radiation therapy" (9 trials), "fluorouracil" (7 trials), "Pemetrexed" (6 trials) and "Carboplatin" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Centre Hospitalier de Mulhouse
The vast majority of trials in "Centre Hospitalier de Mulhouse" are
121 trials for "All" genders, 13 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Centre Hospitalier de Mulhouse
Currently, there are 34 active trials in "Centre Hospitalier de Mulhouse".
1 are not yet recruiting,
21 are recruiting,
11 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 76 completed trials in Centre Hospitalier de Mulhouse,
undefined suspended trials,
and 9 terminated clinical trials to date.
Out of the total trials that were conducted in Centre Hospitalier de Mulhouse, 0 "Phase 1"
clinical trials were conducted, 38 "Phase 2" clinical
trials and 53 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 20 trials that are defined as “Not Applicable".
Departments of Centre Hospitalier de Mulhouse
Centre Hospitalier de Mulhouse has several departments that took part in Clinical trials: "HOPITAL E. MULLER - Hématologie" - 5 trials, "Service de Pneumologie" - 2 trials, "Office-based Specialist in vascular medecine" - 2 trials